课题基金 / 基金详情

Development of gastrointestinal track-targeted biologics to improve the treatment of inflammatory bowel disease (IBD)

Development of gastrointestinal track-targeted biologics to improve the treatment of inflammatory bowel disease (IBD)
开发胃肠道靶向生物制剂以改善炎症性肠病（IBD）的治疗
批准号：
450939
负责人：
Gariepy Jean
金额：
$63.25万
依托单位：
Sunnybrook Research Institute (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
未结题
起止时间：
2021-09-01 至 2026-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=450939&lang=en
关键词：
Anti-Inflammatory Agents Anti-Tnf Alpha Agents Bi-Specific Proteins Carcinoembryonic Antigen Crohn'S Disease Intestinal Bowel Disease Localized Delivery To The Gut Single Chain Fv Targeted Biologics Ulcerative Colitis

项目摘要

项目成果

Gariepy Jean的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Inflammatory bowel disease (IBD) is a term that groups together chronic inflammatory diseases of the digestive tract, notably Crohn's disease and ulcerative colitis. It is projected that IBD will affect about 1% of our country's population by 2030. IBD ty
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery and development of VISTA antagonists that restore antitumor immunity
Understanding and harnessing the therapeutic potential of VISTA: a PD-1-like negative immune checkpoint regulator
Design and in vivo delivery of novel anti-inflammatory agents
Targeted imaging and therapy of breast cancers using Tn antigen-specific DNA aptamers
  • 批准号：
    187558
  • 项目类别：
    Operating Grants
  • 资助金额：
    $7.29万
  • 财政年份：
    2009
  • 负责人：
    Gariepy Jean
  • 依托单位：
    University Health Network (Toronto)